G1–S Control and the Restriction Point

Core Concept

The G1–S transition is the cell's main decision point: it commits the cell to a full round of division. The central molecular switch is the retinoblastoma protein (Rb), which in its underphosphorylated state binds and inhibits the E2F family of transcription factors. Mitogen-driven cyclin D–Cdk4/6 first phosphorylates Rb, and cyclin E–Cdk2 completes Rb hyperphosphorylation, releasing E2F to transcribe genes required for DNA synthesis. The point at which the cell no longer needs external growth signals to finish the cycle is the restriction point. DNA damage arrests this process through p53, which induces the CDK inhibitor p21.

Key Components

• Mitogens (growth factors): Drive cyclin D expression via Ras–MAPK and PI3K pathways.
• Cyclin D–Cdk4/6: The mitogen sensor; initiates Rb phosphorylation.
• Rb (retinoblastoma protein): Pocket protein; binds and represses E2F.
• E2F: Transcription factor family driving S-phase genes (DNA polymerases, cyclin E, cyclin A, etc.).
• Cyclin E–Cdk2: Completes Rb hyperphosphorylation; also phosphorylates other replication targets.
• p16 (INK4a): Inhibits Cdk4/6 (activated by stress/oncogene signals).
• p53 and p21: DNA-damage checkpoint — p53 induces p21, which inhibits Cdk2 and Cdk4/6.
• Restriction point (R point): Late-G1 commitment threshold.

Mechanism / How It Works

1. Mitogen input: Growth factors activate Ras–MAPK and PI3K–Akt, raising cyclin D levels and stabilizing it. Cyclin D binds Cdk4/6.
2. Early Rb phosphorylation: Cyclin D–Cdk4/6 phosphorylates Rb at specific sites, partially inactivating it (hypophosphorylation). This step is mitogen-dependent and reversible.
3. E2F release and positive feedback: Partially released E2F transcribes cyclin E (and A). Cyclin E–Cdk2 then hyperphosphorylates Rb on additional sites, fully releasing E2F — a positive-feedback loop that makes the transition switch-like and, once engaged, independent of further mitogen signal. This is the molecular basis of the restriction point.
4. S-phase entry: Freed E2F drives expression of replication machinery (ORC components, DNA polymerases, MCM helicases, cyclins E and A), committing the cell to replicate DNA.
5. Checkpoint brake: If DNA is damaged, ATM/ATR activate p53, which induces p21. p21 inhibits cyclin E–Cdk2 (and cyclin D–Cdk4/6), keeping Rb active and E2F sequestered, arresting the cell in G1.

Energy and Directionality

Rb phosphorylation consumes ATP (by Cdk4/6 and Cdk2), and the E2F positive-feedback loop (cyclin E–Cdk2 hyperphosphorylating Rb → more E2F → more cyclin E) is the energetic/kinetic engine that makes the restriction point irreversible. Once the loop engages, the transcriptional program is self-sustaining, so the cell commits — this is why passing the R point is the point of no return for a division cycle. Reversal (e.g., by p21-mediated arrest) requires actively re-establishing the underphosphorylated Rb state.

Experimental Evidence / Technique

• Rb as tumor suppressor: Retinoblastoma arises from biallelic RB1 inactivation — the two-hit model of Knudson. Loss of Rb releases E2F constitutively.
• DNA tumor viruses: SV40 large T antigen, adenovirus E1A, and HPV E7 bind and inactivate Rb, forcing E2F activity — a direct demonstration that Rb is a brake on proliferation.
• Serum starvation/readdition: Cells arrested in G0 by serum withdrawal re-enter G1 and pass the restriction point only after mitogen addition; after the R point, mitogen withdrawal no longer stops them.
• Rb phospho-specific antibodies: Track the progressive phosphorylation (hypo- vs. hyperphosphorylated Rb) through G1.
• p21/p16 knockouts and CDK4/6 inhibitors: Show that blocking Cdk4/6 prevents Rb phosphorylation and arrests cells in G1.

How it works

1. Mitogen input: Growth factors activate Ras–MAPK and PI3K–Akt, raising cyclin D levels and stabilizing it. Cyclin D binds Cdk4/6.
2. Early Rb phosphorylation: Cyclin D–Cdk4/6 phosphorylates Rb at specific sites, partially inactivating it (hypophosphorylation). This step is mitogen-dependent and reversible.
3. E2F release and positive feedback: Partially released E2F transcribes cyclin E (and A). Cyclin E–Cdk2 then hyperphosphorylates Rb on additional sites, fully releasing E2F — a positive-feedback loop that makes the transition switch-like and, once engaged, independent of further mitogen signal. This is the molecular basis of the restriction point.
4. S-phase entry: Freed E2F drives expression of replication machinery (ORC components, DNA polymerases, MCM helicases, cyclins E and A), committing the cell to replicate DNA.
5. Checkpoint brake: If DNA is damaged, ATM/ATR activate p53, which induces p21. p21 inhibits cyclin E–Cdk2 (and cyclin D–Cdk4/6), keeping Rb active and E2F sequestered, arresting the cell in G1.

Common confusions

• Rb is not a transcription factor: It is a co-repressor/regulator that binds and inhibits E2F; E2F is the transcription factor.
• Phosphorylation state matters: Rb is active as a brake when underphosphorylated and inactive when hyperphosphorylated — the opposite of what intuition might suggest.
• Restriction point vs. G1/S checkpoint: The R point is a commitment threshold (mitogen-dependent); the G1/S checkpoint is a damage sensor (p53/p21) that can arrest the cycle at the boundary.
• p16 vs. p21: Both inhibit CDKs (p16 → Cdk4/6; p21 → Cdk2/Cdk4/6), but p16 responds to oncogenic stress and p21 to DNA damage via p53.

Quick review

• Mitogens → cyclin D–Cdk4/6 → Rb partial phosphorylation → cyclin E–Cdk2 → Rb hyperphosphorylation → E2F free → S-phase gene transcription → S phase.
• Restriction point: positive-feedback switch (E2F → cyclin E → more Rb-P).
• Brakes: p16 (Cdk4/6), p53→p21 (Cdk2/4/6); DNA tumor viruses disable Rb.